- Home
- ASAN vs EWTX Comparison
ASAN vs EWTX Comparison
Compare ASAN & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASAN
- EWTX
- Stock Information
- Founded
- ASAN 2008
- EWTX 2017
- Country
- ASAN United States
- EWTX United States
- Employees
- ASAN N/A
- EWTX N/A
- Industry
- ASAN Retail: Computer Software & Peripheral Equipment
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- ASAN Technology
- EWTX Health Care
- Exchange
- ASAN Nasdaq
- EWTX Nasdaq
- Market Cap
- ASAN 2.7B
- EWTX 3.3B
- IPO Year
- ASAN 2020
- EWTX 2021
- Fundamental
- Price
- ASAN $15.74
- EWTX $32.20
- Analyst Decision
- ASAN Hold
- EWTX Buy
- Analyst Count
- ASAN 17
- EWTX 6
- Target Price
- ASAN $15.19
- EWTX $41.17
- AVG Volume (30 Days)
- ASAN 1.6M
- EWTX 680.7K
- Earning Date
- ASAN 12-05-2024
- EWTX 11-07-2024
- Dividend Yield
- ASAN N/A
- EWTX N/A
- EPS Growth
- ASAN N/A
- EWTX N/A
- EPS
- ASAN N/A
- EWTX N/A
- Revenue
- ASAN $689,298,000.00
- EWTX N/A
- Revenue This Year
- ASAN $12.59
- EWTX N/A
- Revenue Next Year
- ASAN $11.75
- EWTX N/A
- P/E Ratio
- ASAN N/A
- EWTX N/A
- Revenue Growth
- ASAN 13.65
- EWTX N/A
- 52 Week Low
- ASAN $11.05
- EWTX $5.93
- 52 Week High
- ASAN $23.44
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- ASAN 75.63
- EWTX 48.00
- Support Level
- ASAN $13.53
- EWTX $29.82
- Resistance Level
- ASAN $15.24
- EWTX $32.80
- Average True Range (ATR)
- ASAN 0.55
- EWTX 1.85
- MACD
- ASAN 0.12
- EWTX -0.62
- Stochastic Oscillator
- ASAN 97.29
- EWTX 28.67
About ASAN Asana Inc.
Asana is a provider of collaborative work management software delivered via a cloud-based SaaS model. The firm's solution offers scalable, dynamic tools to improve the efficiency of project and process management across countless use cases, including marketing programs, managing IT approvals, and performance management. Asana's offering supports workflow management across teams, provides real time visibility into projects, and reporting and automation capabilities. The firm generates revenue via software subscriptions on a per seat basis.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.